Functional characterization of T lymphocytes derived from patients with acute myelogenius leukemia and chemotherapy-induced leukopenia

Cancer Immunology, Immunotherapy

Volumn 53, Issue 8, 2004, Pages 740-747

  Wendelbo, Øystein ^a   Nesthus, Ingerid ^a   Sjo, Malvin ^a   Paulsen, Kristin ^a   Ernst, Peter ^a   Bruserud, Øystein ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute myelogenous leukemia; Chemotherapy; T lymphocytes

Indexed keywords

AMSAKRINE; ANTILEUKEMIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IDARUBICIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 4; METHOTREXATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; THYMIDINE; TIOGUANINE; TRITIUM; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD ANALYSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LEUKOPENIA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MONOCYTE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ASSAY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD28; ANTIGENS, CD3; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; CELL DIVISION; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOPENIA; MALE; MIDDLE AGED; MONOCYTES; T-LYMPHOCYTES; THYMIDINE;

EID: 3242698607     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Anaissie E (1992) Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 14 [Suppl 1]:S43
2. Baird AM, Gerstein RM, Berg LJ (1999) The role of cytokine receptor signalling in lymphocyte development. Curr Opin Immunol 11:157
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. Br J Haematol 33:451
4. Bishop JF, Matthews JP, Young GA, Szer J, Gillett A, Joshua D, Bradstock K, Enno A, Wolf MM, Fox R, Cobcroft R, Herrmann R, van der Weyden M, Lowenthal RM, Page F, Garson OM, Juneja (1990) A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood 87:1710
5. Bloemena E, Roos MT, van Heijst JL, Vossen JM, Schellekens PT (1989) Whole blood lymphocyte cultures. J Immunol Methods 122:161
6. Bruserud Ø (1998) Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia: characterization of the cytokine repertoire of clonogenic T cells. Cancer Immunol Immunother 46:221
7. Bruserud Ø (1998) IL-4, IL-10 and IL-13 in acute myelogenous leukemia. Cytokines Cell Mol Ther 4:187
8. Bruserud Ø, Ulvestad E (2000) Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia. J Interferon Cytokine Res 20:947
9. Bruserud Ø, Ulvestad E (2000) Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation. Cell Immunol 206:36
10. Bruserud Ø, Ulvestad E, Halstensen A, Berentsen S, Bergheim J, Nesthus I (1997) Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia. Eur J Haematol 59:269
11. Bruserud Ø, Ulvestad E, Berentsen S, Bergheim J, Nesthus I (1998) T lymphocyte functions in acute leukaemia patients with severe chemotherapy-induced cytopenia: characterization of clonogenic T cell proliferation. Scand J Immunol 47:54
12. Esber E, DiNicola W, Movassaghi N, Leikin S (1976) T and B lymphocytes in leukemia therapy. Am J Hematol 1:211
13. Fidel PL, Sobel JD (1994) The role of cell-mediated immunity in candidiasis. Trends Microbiol 2:202
14. Fonseca AM, Pereira CF, Porto G, Arosa FA (2003) Red blood cells promote survival and cell cycle progression of human peripheral blood T cells independently of CD58/LFA-3 and heme compounds. Cell Immunol 224:17
15. Hamilton G (2002) GM-CSF in inflammation and autoimmunity. Trends Immunol 23:403
16. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. J Clin Oncol 17:3835
17. Koll BS, Brown AE (1993) The changing epidemiology of infections in cancer hospitals. Clin Infect Dis 17[Suppl 2]:S322
18. Kraut EH, Neff JC, Bouroncle BA, Gochnour D, Grever MR (1990) Immunosuppressive effects of pentostatin. J Clin Oncol 8:848
19. Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, Hooberman AL, Westbrook CA, Arthur DC, George SL, Bloomfield CD, Schiffer CA. (1995) A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811. Blood 85:2025
20. Mackall CL (1999) T cell immunodeficiency following cytotoxic antineoplastic therapy: a review. Oncologist 4:370
21. Mackall CL, Fleischer TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Rubio M, Palau L, Vivas JR, del Potro E, Diaz-Mediavilla J, Alvarez A, Martinez R, Picazo JJ (1994) Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84:2221
22. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E (1994) Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331:896
23. Rubio M, Palau L, Vivas JR, del Potro E, Diaz-Mediavilla J, Alvarez A, Martinez R, Picazo JJ (1994) Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol 15:101
24. Romani L, Howard DH (1995) Mechanisms of resistance to fungal infections. Curr Opin Immunol 7:517
25. Shurin MR, Esche C, Lotze MT (1998) FLT3: receptor and ligand. Cytokine Growth Factor Rev 9:37
26. Urba WJ, Baseler MW, Kopp WC, Steis RG, Clark JW, Smith JW, Coggin DL, Longo DL (1989) Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia. Blood 73:38.
27. Wendelbo Ø, Bruserud Ø (2003) Functional evaluation of proliferative T cell responses in patients with severe T lymphopenia: characterization of optimal culture conditions and standardized activation signals for a simple whole blood assay. J Hematother Stem Cell Res 12:525
28. Young LS (1994) Management of infections in leukemia and lymphoma. In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host, 3rd edn. Plenum, New York, p 95